Sample | Concentration (μg/ml)) | MDA formation (A540) | Inhibition rate (%) |
PPM | 125 | 0.280 ± 0.005a | 16.67 |
250 | 0.246 ± 0.004a | 24.79 | |
500 | 0.234 ± 0.005a | 32.36 | |
1000 | 0.180 ± 0.005a | 46.43 | |
PMA | 125 | 0.294 ± 0.004a | 12.5 |
250 | 0.284 ± 0.007a | 17.48 | |
500 | 0.184 ± 0.004a | 40.24 | |
1000 | 0.162 ± 0.011a | 51.79 | |
PMB | 125 | 0.280 ± 0.007a | 16.67 |
250 | 0.268 ± 0.006a | 24.24 | |
500 | 0.204 ± 0.006a | 39.29 | |
1000 | 0.186 ± 0.004a | 44.64 | |
PMC-1 | 125 | 0.312 ± 0.004a | 7.14 |
250 | 0.286 ± 0.003a | 14.88 | |
500 | 0.232 ± 0.004a | 30.95 | |
1000 | 0.214 ± 0.006a | 36.31 | |
Control | 0 | 0.336 ± 0.002a | ------- |